What's in LEGACY PHARMA's pipeline?

LEGACY PHARMA has 5 drugs in our index: 5 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with LEGACY PHARMA's portfolio?

Top competitors by shared drug class: , ANI Pharmaceuticals, Assistance Publique - Hôpitaux de Paris, Acrotech Biopharma Inc., Allergan.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/legacy-pharma.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-15 · How we verify

LEGACY PHARMA — Portfolio Competitive Intelligence Brief

LEGACY PHARMA pipeline: 5 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Lotronex	ALOSETRON	marketed	Serotonin-3 Receptor Antagonist	5-hydroxytryptamine receptor 3A	Neuroscience	2000-01-01
Naftin	NAFTIFINE	marketed	Allylamine Antifungal	Sigma non-opioid intracellular receptor 1	Infectious Disease	1988-01-01
Ridaura	AURANOFIN	marketed	auranofin	D(3) dopamine receptor	Immunology	1985-01-01
Cloderm	CLOCORTOLONE PIVALATE	marketed	Corticosteroid	Glucocorticoid receptor	Oncology	1977-01-01
Imuran	AZATHIOPRINE	marketed	Purine Antimetabolite [EPC]	ATP-binding cassette sub-family G member 2	Immunology	1968-01-01

Therapeutic area mix

Immunology · 2
Infectious Disease · 1
Neuroscience · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

· 2 shared drug classes
ANI Pharmaceuticals · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Acrotech Biopharma Inc. · 1 shared drug class
Allergan · 1 shared drug class
Aramis Biosciences, Inc. · 1 shared drug class
AbbVie · 1 shared drug class
AIDS Malignancy Consortium · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for LEGACY PHARMA:

Cite this brief

Drug Landscape (2026). LEGACY PHARMA — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/legacy-pharma. Accessed 2026-05-15.